CHEK2 and glioblastoma: Indeed, although both CD133− and CD133+ GBM cells activate the ataxia-telangiectasia-mutated (ATM), Rad17, Chk1, and Chk2 checkpoint proteins, only CD133+ GSCs potently phosphorylates Chk1 and Chk2 [8].